|Day Low/High||92.11 / 95.87|
|52 Wk Low/High||66.93 / 101.73|
Merck buys French digital animal identification solutions company Antelliq Group.
It was a big year for mergers and acquisitions, as predicted. What now? The trend can't last forever.
There's plenty at stake for biotech and managed care stocks in the November 6 election.
Global stocks are on track to close out one of the worst months since the financial crisis on a high note Wednesday, with investors cautiously moving cash into beaten-down equities that are trading at their cheapest levels in more than two years even as headline risks related to U.S.-China trade rising interest rates and weakening corporate earnings continue to challenge sentiment.
This stock moves fast, so acting on target prices and panic points is essential.
Jim Cramer is concerned about risk, and the Fed. But, he says, you need to get in there and talk with the CEOs to get the real story about the economy.
Jim Cramer takes a closer look at Express Scripts, Lockheed Martin, Raytheon, Abiomed.
Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.
Straying from these names could land you in quicksand as the 4th quarter begins.
Here's what you need to know for Wednesday, Sept. 18.
The most recent short interest data has been released for the 08/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Stocks are mixed on Thursday as investors brace for another potentially damaging escalation in the ongoing trade war between the U.S. and China.
U.S. stock futures rise slightly as investors brace for a potentially damaging escalation in U.S. and China trade war; the Justice Department is reportedly close to giving the green light to two mega deals in the healthcare sector; CBS and National Amusements are in settlement talks, a report says.
Here's what you need to know now for Wednesday, Sept. 5.
Stocks end Tuesday with solid gains as concerns over Turkey's currency crisis ease.
U.S. stock futures rise on Tuesday as investors cautiously return to risk markets; Home Depot reports earnings; Tesla's Elon Musk says he's working with Silver Lake Partners and Goldman Sachs as advisers on his plans to take the electric car company private.
Sometimes you gotta have faith, but you also have to be a little more skeptical.
Stocks ended higher Tuesday after China moved to support shares in Shanghai and on positive earnings and takeover talk.
Cigna argues Carl Icahn is only looking out for himself in trying to block Express Scripts deal.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's stocks from the floor of the New York Stock Exchange.
Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.
The summer battle on Wall Street is on: Cigna vs. billionaire activist investor Carl Icahn. Stocks, meanwhile, continue to ascend to new heights despite a host of concerns.
U.S. stock futures are higher on Tuesday as earnings continue to impress; Walt Disney, Snap and Papa John's report earnings on Tuesday; the Justice Department challenges a judge's approval of the AT&T-Time Warner merger.
Billionaire Investor Carl Icahn urged Cigna shareholders Tuesday to reject the company's planned acquisition of Express Scripts Holdings Co., calling the deal a "$60 billion folly".
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.